Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind study

The expected therapeutic effect of estrogen as an adjunct treatment to antipsychotics in women suffering from schizophrenia for relapse prevention was to be tested under real-life conditions. A multicenter, randomized, placebo-controlled, double-blind, cross-over study based on an A-B-A-B (and/or B-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bergemann, Niels (VerfasserIn) , Mundt, Christoph (VerfasserIn) , Parzer, Peter (VerfasserIn) , Pakrasi, Manoshi (VerfasserIn) , Eckstein-Mannsperger, Ursula K. (VerfasserIn) , Haisch-Gomes, Susanne (VerfasserIn) , Salbach, Birgit (VerfasserIn) , Klinga, Klaus (VerfasserIn) , Runnebaum, Benno (VerfasserIn) , Resch, Franz (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 13 January 2005
In: Schizophrenia research
Year: 2005, Jahrgang: 74, Heft: 2, Pages: 125-134
ISSN:1573-2509
DOI:10.1016/j.schres.2004.12.009
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.schres.2004.12.009
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0920996404004669
Volltext
Verfasserangaben:Niels Bergemann, Christoph Mundt, Peter Parzer, Manoshi Pakrasi, Ursula Eckstein-Mannsperger, Susanne Haisch, Birgit Salbach, Klaus Klinga, Benno Runnebaum, Franz Resch

MARC

LEADER 00000caa a2200000 c 4500
001 1742822142
003 DE-627
005 20241118093447.0
007 cr uuu---uuuuu
008 201215s2005 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.schres.2004.12.009  |2 doi 
035 |a (DE-627)1742822142 
035 |a (DE-599)KXP1742822142 
035 |a (OCoLC)1341383598 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 11  |2 sdnb 
100 1 |a Bergemann, Niels  |e VerfasserIn  |0 (DE-588)170531007  |0 (DE-627)060634154  |0 (DE-576)131408437  |4 aut 
245 1 0 |a Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia  |b results of a placebo-controlled double-blind study  |c Niels Bergemann, Christoph Mundt, Peter Parzer, Manoshi Pakrasi, Ursula Eckstein-Mannsperger, Susanne Haisch, Birgit Salbach, Klaus Klinga, Benno Runnebaum, Franz Resch 
264 1 |c 13 January 2005 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.12.2020 
520 |a The expected therapeutic effect of estrogen as an adjunct treatment to antipsychotics in women suffering from schizophrenia for relapse prevention was to be tested under real-life conditions. A multicenter, randomized, placebo-controlled, double-blind, cross-over study based on an A-B-A-B (and/or B-A-B-A) design was applied. Forty-six hypoestrogenic women with schizophrenia hospitalized for the first time or repeatedly were included in the study. Their average age was 37.9 and they had been suffering from schizophrenia for 8.4 years. During the drug treatment phases, they received a three-phase estrogen-gestagen combination drug (17β-estradiol+norethisterone acetate) in addition to an antipsychotic drug. Significant effects of the adjuvant hormone replacement therapy on the estradiol levels could be observed, and high and low levels of estradiol prevailed in the active drug and placebo phases, respectively. We did not find any difference either in defined relapse events or in the psychopathology between estradiol replacement and placebo phases. Neither did the required antipsychotic doses or the tolerance data differ between the two phases. Thus, the results of our study do not confirm the hypothesis that a combined estradiol/antipsychotic therapy is superior to an antipsychotic monotherapy for relapse prevention. 
650 4 |a Estradiol 
650 4 |a Estrogen protection hypothesis 
650 4 |a Estrogens 
650 4 |a Hormone replacement therapy 
650 4 |a Hypoestrogenism 
650 4 |a Schizophrenia 
700 1 |a Mundt, Christoph  |d 1944-  |e VerfasserIn  |0 (DE-588)123533759  |0 (DE-627)082613397  |0 (DE-576)293753822  |4 aut 
700 1 |a Parzer, Peter  |e VerfasserIn  |0 (DE-588)1030557837  |0 (DE-627)735716870  |0 (DE-576)378408712  |4 aut 
700 1 |a Pakrasi, Manoshi  |e VerfasserIn  |4 aut 
700 1 |a Eckstein-Mannsperger, Ursula K.  |e VerfasserIn  |0 (DE-588)134862373X  |0 (DE-627)1908848294  |4 aut 
700 1 |a Haisch-Gomes, Susanne  |e VerfasserIn  |0 (DE-588)1222982714  |0 (DE-627)1742239226  |4 aut 
700 1 |a Salbach, Birgit  |e VerfasserIn  |0 (DE-588)1125046694  |0 (DE-627)879378891  |0 (DE-576)170863999  |4 aut 
700 1 |a Klinga, Klaus  |d 1941-  |e VerfasserIn  |0 (DE-588)1020326328  |0 (DE-627)691183147  |0 (DE-576)170162419  |4 aut 
700 1 |a Runnebaum, Benno  |d 1933-  |e VerfasserIn  |0 (DE-588)105969656  |0 (DE-627)690916620  |0 (DE-576)355816253  |4 aut 
700 1 |a Resch, Franz  |d 1953-  |e VerfasserIn  |0 (DE-588)136669972  |0 (DE-627)585458170  |0 (DE-576)301199612  |4 aut 
773 0 8 |i Enthalten in  |t Schizophrenia research  |d Amsterdam [u.a.] : Elsevier Science, 1988  |g 74(2005), 2, Seite 125-134  |h Online-Ressource  |w (DE-627)306710307  |w (DE-600)1500726-1  |w (DE-576)082435820  |x 1573-2509  |7 nnas  |a Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia results of a placebo-controlled double-blind study 
773 1 8 |g volume:74  |g year:2005  |g number:2  |g pages:125-134  |g extent:10  |a Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia results of a placebo-controlled double-blind study 
856 4 0 |u https://doi.org/10.1016/j.schres.2004.12.009  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0920996404004669  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201215 
993 |a Article 
994 |a 2005 
998 |g 136669972  |a Resch, Franz  |m 136669972:Resch, Franz  |d 910000  |d 910600  |d 50000  |e 910000PR136669972  |e 910600PR136669972  |e 50000PR136669972  |k 0/910000/  |k 1/910000/910600/  |k 0/50000/  |p 10  |y j 
998 |g 105969656  |a Runnebaum, Benno  |m 105969656:Runnebaum, Benno  |d 50000  |e 50000PR105969656  |k 0/50000/  |p 9 
998 |g 1125046694  |a Salbach, Birgit  |m 1125046694:Salbach, Birgit  |p 7 
998 |g 1030557837  |a Parzer, Peter  |m 1030557837:Parzer, Peter  |d 910000  |d 910600  |e 910000PP1030557837  |e 910600PP1030557837  |k 0/910000/  |k 1/910000/910600/  |p 3 
998 |g 123533759  |a Mundt, Christoph  |m 123533759:Mundt, Christoph  |d 910000  |d 910600  |e 910000PM123533759  |e 910600PM123533759  |k 0/910000/  |k 1/910000/910600/  |p 2 
998 |g 170531007  |a Bergemann, Niels  |m 170531007:Bergemann, Niels  |d 50000  |e 50000PB170531007  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1742822142  |e 382567973X 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"10 S."}],"id":{"doi":["10.1016/j.schres.2004.12.009"],"eki":["1742822142"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia","subtitle":"results of a placebo-controlled double-blind study","title":"Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia"}],"relHost":[{"id":{"issn":["1573-2509"],"zdb":["1500726-1"],"eki":["306710307"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1988 -"],"part":{"text":"74(2005), 2, Seite 125-134","pages":"125-134","issue":"2","year":"2005","extent":"10","volume":"74"},"recId":"306710307","origin":[{"dateIssuedDisp":"1988-","publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1988"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Schizophrenia research","title":"Schizophrenia research","subtitle":"an international multidisciplinary journal"}],"note":["Gesehen am 09.12.04","Ungezählte Beil.: Supplement"],"disp":"Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia results of a placebo-controlled double-blind studySchizophrenia research"}],"person":[{"family":"Bergemann","given":"Niels","display":"Bergemann, Niels","role":"aut"},{"family":"Mundt","given":"Christoph","display":"Mundt, Christoph","role":"aut"},{"given":"Peter","family":"Parzer","role":"aut","display":"Parzer, Peter"},{"given":"Manoshi","family":"Pakrasi","role":"aut","display":"Pakrasi, Manoshi"},{"role":"aut","display":"Eckstein-Mannsperger, Ursula K.","given":"Ursula K.","family":"Eckstein-Mannsperger"},{"given":"Susanne","family":"Haisch-Gomes","role":"aut","display":"Haisch-Gomes, Susanne"},{"given":"Birgit","family":"Salbach","role":"aut","display":"Salbach, Birgit"},{"role":"aut","display":"Klinga, Klaus","given":"Klaus","family":"Klinga"},{"given":"Benno","family":"Runnebaum","role":"aut","display":"Runnebaum, Benno"},{"display":"Resch, Franz","role":"aut","family":"Resch","given":"Franz"}],"language":["eng"],"origin":[{"dateIssuedKey":"2005","dateIssuedDisp":"13 January 2005"}],"recId":"1742822142","name":{"displayForm":["Niels Bergemann, Christoph Mundt, Peter Parzer, Manoshi Pakrasi, Ursula Eckstein-Mannsperger, Susanne Haisch, Birgit Salbach, Klaus Klinga, Benno Runnebaum, Franz Resch"]},"note":["Gesehen am 15.12.2020"]} 
SRT |a BERGEMANNNESTROGENAS1320